Page 603 - Read Online

Jiang et al. Hepatoma Res 2020;6:52 I http://dx.doi.org/10.20517/2394-5079.2020.47 Page 11 of 13

REFERENCES
1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
2. Ying Q, Wang Y. Global prevalence and trend of liver cancer. China Cancer 2020;29:185-91.
3. Howlader N, Noone A, Krapcho M, Miller D, Brest A, et al. SEER cancer statistics review, 1975-2016, National Cancer Institute. In:
Bethesda MD, editor. Based on November 2018 SEER data submission posted to the SEER web site, April 2019. Available from: https://
seer.cancer.gov/csr/1975_2016/. [Last accessed on 3 Jul 2020]
4. Cancer Hospital Chinese Academy of Medical Science. Chinese Guideline for Cancer Registration (2016)ed. Beijing: People’s Medical
Publishing House(PMPH) Pub; 2016. pp. 33-75.
5. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982;38: 933-42.
6. Jung KW, Park S, Kong HJ, Won YJ, Lee JY, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009.
Cancer Res Treat 2012;44:11-24.
7. Jung KW, Won YJ, Kong HJ, Oh CM, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2011.
Cancer Res Treat 2014;46:109-23.
8. Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012.
Cancer Res Treat 2015;47:127-41.
9. Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014.
Cancer Res Treat 2017;49:292-305.
10. Jung KW, Won YJ, Kong HJ, Lee ES. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2016. Cancer Res Treat
2019;51:417-30.
11. Jung KW, Won YJ, Kong HJ, Oh CM, Shin A, et al. Survival of korean adult cancer patients by stage at diagnosis, 2006-2010: national
cancer registry study. Cancer Res Treat 2013;45:162-71.
12. Matsuda T, Ajiki W, Marugame T, Ioka A, Tsukuma H, et al. Population-based survival of cancer patients diagnosed between 1993 and
1999 in Japan: a chronological and international comparative study. Jpn J Clin Oncol 2011;41:40-51.
13. Chia KS, Du WB, Sankaranarayanan R, Sankila R, Seow A, et al. Population-based cancer survival in Singapore, 1968 to 1992: an
overview. Int J Cancer 2001;93:142-7.
14. Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, et al. Hepatocellular carcinoma: trends of incidence and survival in Europe and
the United States at the end of the 20th century. Am J Gastroenterol 2007;102:1661-70.
15. Howlader N, Noone AM, Krapcho M, Miller D, Brest A, et al. SEER Cancer Statistics Review, 1975-2017, National Cancer Institute.
Available from: https://seer.cancer.gov/csr/1975_2017/. [Last accessed on 30 Jun 2020].
16. Sant M, Aareleid T, Berrino F, Bielska Lasota M, et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and
commentary. Ann Oncol 2003;14:v61-118.
17. Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, et al. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999.
Results and commentary. Eur J Cancer 2009;45:931-91.
18. Dunbar JK, Dillon J, Garden OJ, Brewster DH. Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national
cancer registry data. HPB 2013;15:279-85.
19. Bossard N, Velten M, Remontet L, Belot A, Maarouf N, et al. Survival of cancer patients in France: a population-based study from The
Association of the French Cancer Registries (FRANCIM). Eur J Cancer 2007;43:149-60.
20. Guiu B, Minello A, Cottet V, Lepage C, Hillon P, et al. A 30-year, population-based study shows improved management and prognosis of
hepatocellular carcinoma. Clin Gastroenterol Hepatol 2010;8:986-91.
21. Chirlaque MD, Salmeron D, Galceran J, Ameijide A, Mateos A, et al. Cancer survival in adult patients in Spain. Results from nine
population-based cancer registries. Clin Transl Oncol 2018;20:201-11.
22. Levi F, Randimbison L, Te VC, Franceschi S, La Vecchia C. Trends in survival for patients diagnosed with cancer in Vaud, Switzerland,
between 1974 and 1993. Ann Oncol 2000;11:957-63.
23. Storm HH, Engholm G, Hakulinen T, Tryggvadottir L, Klint A, et al. Survival of patients diagnosed with cancer in the Nordic countries
up to 1999-2003 followed to the end of 2006. A critical overview of the results. Acta Oncol 2010;49:532-44.
24. Klint A, Engholm G, Storm HH, Tryggvadottir L, Gislum M, et al. Trends in survival of patients diagnosed with cancer of the digestive
organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010;49:578-607.
25. Redaniel MT, Laudico A, Mirasol-Lumague MR, Gondos A, Brenner H. Cancer survival differences between European countries and an
urban population from the Philippines. Eur J Public Health 2011;21:221-8.
26. Tsukuma H, Ajiki W, Ioka A, Oshima A. Survival of cancer patients diagnosed between 1993 and 1996: a collaborative study of
population-based cancer registries in Japan. Jpn J Clin Oncol 2006;36:602-7.
27. Laudico AV, Mirasol-Lumague MR, Mapua CA, Uy GB, Toral JA, et al. Cancer incidence and survival in Metro Manila and Rizal
Province, Philippines. Jpn J Clin Oncol 2010;40:603-12.
28. Li Y, Yu L, Na J, Li S, Liu L, et al. Survival of cancer patients in northeast China: analysis of sampled cancers from population-based
cancer registries. Cancer Res Treat 2017;49:1106-13.
29. Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, et al. Annual report to the nation on the status of cancer, 1975-2014, featuring
survival. J Natl Cancer Inst 2017;109:djx030.
30. Ellison LF, Wilkins K. An update on cancer survival. Health Rep 2010;21:55-60.
31. Ellison LF. Measuring the effect of including multiple cancers in survival analyses using data from the Canadian Cancer Registry. Cancer